
Oral Tirzepatide
A daily dual GIP/GLP-1 tablet — deeper appetite control, no injection required.
Dual-agonist care, without the needle.
Tirzepatide works on two gut-hormone pathways at once — GIP and GLP-1 — pairing strong appetite reduction with improved insulin sensitivity. The oral form brings that mechanism into a daily tablet, with the same clinician-led titration.
How it works
Tirzepatide activates both the GLP-1 and GIP receptors. GLP-1 quiets appetite and slows gastric emptying; GIP adds a metabolic layer that supports insulin sensitivity and how your body handles fat. Patients often describe the combination as a deeper, steadier drop in hunger than a single-agonist GLP-1.
The oral formulation uses an absorption enhancer so the peptide survives digestion. You take one tablet each morning on an empty stomach with a small sip of water, then wait about 30 minutes before eating, drinking, or taking other medications.
What to expect
- CadenceOne tablet daily, first thing in the morning.
- DosingConservative start with stepwise increases as tolerance allows.
- TimingEmpty stomach, small sip of water, then ~30 minutes before food or other meds.
- ResponseStrong appetite reduction that often deepens past month three.
- Side-effect patternMild GI symptoms early in titration; a slower step-up improves tolerance.
Oral vs. injection
Who it's for
Oral tirzepatide suits adults who want the dual GIP/GLP-1 mechanism without weekly injections — including patients whose response to a single-agonist GLP-1 has plateaued.
- Adults 18+ with a BMI of 27+ (or 25+ with a weight-related condition).
- You want a deeper appetite response than a single-agonist GLP-1.
- You'd prefer to avoid needles entirely.
- You can keep a consistent morning routine on an empty stomach.
- —Personal or family history of medullary thyroid carcinoma or MEN 2.
- —History of pancreatitis, severe GI disease, or gastroparesis.
- —Currently pregnant, planning pregnancy, or breastfeeding.
- —You can't reliably dose on an empty stomach each morning.

Oral Tirzepatide
A daily dual GIP/GLP-1 tablet — deeper appetite control, no injection required.










